Financials

News Discussions Technicals Forecast Seasonals

4551 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. Its products are mainly used for renal diseases and hemodialysis, human immunodeficiency virus (HIV), skin diseases, and allergies. These include Riona, Remitch, Kayexalate, Corectim, Antebate, Cedarcure, and Miticure. The company was founded by Tokubei Torii in 1872 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

4551 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company